ISPOR Europe 2022 daily round-ups: Day 3

Written by Laura Dormer, Editor
Decision science Editorials Events coverage Health economics Health technology assessment ISPOR Outcomes research Real-world evidence Regulation Stakeholder engagement

Throughout this week, The Evidence Base® is bringing you updates direct from the ISPOR Europe 2022 (6–9 November; Vienna, Austria) meeting! Final poster session It was great to see a busy exhibit hall for the fifth and final poster session of the conference. A huge amount of research has been presented over the course of the conference, with some of the poster highlights from Day 3 including: The Increasing Use of Population-Adjusted Indirect Comparisons in the NICE Health Technology Assessment (HTA) Submission Process and the Response to These Methods Cost-Effectiveness of AZD7442 (Tixagevimab and Cilgavimab) for Pre-exposure Prophylaxis Against COVID-19...

To view this content, please register now for access

It's completely free